litlas
Log inCreate account

Matthias Holdhoff

Active 2005–2025

58
Papers
18,021
Citations
32
h-index
49
i10-index

Citations

Citations per year for Matthias Holdhoff1993: 1 citations2005: 2 citations2006: 1 citations2007: 2 citations2008: 3 citations2009: 6 citations2010: 2 citations2011: 7 citations2012: 11 citations2013: 25 citations2014: 69 citations2015: 156 citations2016: 170 citations2017: 237 citations2018: 390 citations2019: 1,024 citations2020: 1,137 citations2021: 1,136 citations2022: 887 citations2023: 662 citations2024: 1,000 citations2025: 477 citations2026: 23 citations1994–2004: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,132 citing papers, 27.1% of this breakdownChina: 1,566 citing papers, 13.6% of this breakdownItaly: 701 citing papers, 6.1% of this breakdownGermany: 655 citing papers, 5.7% of this breakdownUnited Kingdom: 605 citing papers, 5.2% of this breakdownFrance: 482 citing papers, 4.2% of this breakdownJapan: 408 citing papers, 3.5% of this breakdownSpain: 383 citing papers, 3.3% of this breakdownNetherlands: 350 citing papers, 3% of this breakdownCanada: 326 citing papers, 2.8% of this breakdownAustralia: 282 citing papers, 2.5% of this breakdownSwitzerland: 230 citing papers, 2% of this breakdown
0%27.1%Other 21%

Institutions

Fields

  • Medicine60.7%
  • Biochemistry, Genetics and Molecular Biology32.3%
  • Immunology and Microbiology3.6%
  • Engineering1%
  • Materials Science0.8%
  • Neuroscience0.6%
  • Other1%

Topics

  • Cancer Genomics and Diagnostics11.2%
  • Cancer Immunotherapy and Biomarkers8.7%
  • Glioma Diagnosis and Treatment5%
  • Genetic factors in colorectal cancer4.8%
  • Pancreatic and Hepatic Oncology Research3.3%
  • Lung Cancer Treatments and Mutations3%
  • Other64%

Coauthors

All papers

Open in search
  1. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

    Authors: Dung T. Le, Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne R. Bartlett, Laveet K. Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon Luber, Fay Wong, Nilofer S. Azad, Agnieszka A. Rucki, Dan Laheru, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Tim F. Greten, Austin G. Duffy, Kristen K. Ciombor, Aleksandra Eyring, Bao H. Lam, Andrew K. Joe, Soonmo Peter Kang, Matthias Holdhoff, Ludmila Danilova, Leslie Cope, Christian F. Meyer, Shibin Zhou, Richard M. Goldberg, Deborah K. Armstrong, Katherine M. Bever, Amanda N. Fader, Janis M. Taube, Franck Housseau, David Spetzler, Nianqing Xiao, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, James R. Eshleman, Bert Vogelstein, Robert A. Anders, Luis A. Díaz - Science 2017 cited by 6,766

  2. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

    Authors: Chetan Bettegowda, Mark Sausen, Rebecca Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R. Bartlett, Hao Wang, Brandon Luber, Rhoda M. Alani, Emmanuel S. Antonarakis, Nilofer S. Azad, Alberto Bardelli, Henry Brem, John L. Cameron, Clarence Lee, Leslie A. Fecher, Gary L. Gallia, Peter Gibbs, Dung T. Le, Robert Giuntoli, Michael Goggins, Michael D. Hogarty, Matthias Holdhoff, Seung‐Mo Hong, Yuchen Jiao, Hartmut Juhl, Jaeyeon Kim, Giulia Siravegna, Daniel A. Laheru, Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz - Science Translational Medicine 2014 cited by 5,110

  3. Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

    Authors: Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal, Mehdi Touat, Katherine B. Peters, Jennifer Clarke, Joe Mendez, Shlomit Yust‐Katz, Liam Welsh, Warren Mason, François Ducray, Yoshie Umemura, Burt Nabors, Matthias Holdhoff, Andreas F. Hottinger, Yoshiki Arakawa, Juan Manuel Sepúlveda-Sánchez, Wolfgang Wick, Riccardo Soffietti, James Perry, Pierre Giglio, Macarena de la Fuente, Elizabeth A. Maher, Steven Schoenfeld, Dan Zhao, Shuchi S. Pandya, Lori Steelman, Islam Hassan, Patrick Y. Wen, Timothy F. Cloughesy - New England Journal of Medicine 2023 cited by 719

  4. Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    Authors: Burt Nabors, Jana Portnow, Manmeet S. Ahluwalia, Joachim M. Baehring, Henry Brem, Steven Brem, Nicholas Butowski, Jian Campian, Stephen W. Clark, Andrew J. Fabiano, Peter Forsyth, Jona A. Hattangadi‐Gluth, Matthias Holdhoff, Craig Horbinski, Larry Junck, Thomas Kaley, Priya Kumthekar, Jay S. Loeffler, Maciej M. Mrugała, Seema Nagpal, Manjari Pandey, Ian F. Parney, Katherine B. Peters, Vinay K. Puduvalli, Ian Robins, Jason K. Rockhill, Chad G. Rusthoven, Nicole Shonka, Dennis C. Shrieve, Lode J. Swinnen, Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan Darlow - Journal of the National Comprehensive Cancer Network 2020 cited by 564

  5. Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma

    Authors: Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat, Elizabeth A. Maher, Macarena I. de la Fuente, Matthias Holdhoff, Gregory M. Coté, Howard A. Burris, Filip Jankú, Robert J. Young, Raymond Y. Huang, Liewen Jiang, Sung Choe, Bin Fan, Katharine Yen, Min Lu, Chris Bowden, Lori Steelman, Shuchi S. Pandya, Timothy F. Cloughesy, Patrick Y. Wen - Journal of Clinical Oncology 2020 cited by 307

  6. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022

    Authors: Craig Horbinski, Burt Nabors, Jana Portnow, Joachim M. Baehring, Ankush Bhatia, Orin Bloch, Steven Brem, Nicholas Butowski, Donald M. Cannon, Samuel T. Chao, Milan G. Chheda, Andrew J. Fabiano, Peter Forsyth, Pierre Gigilio, Jona A. Hattangadi‐Gluth, Matthias Holdhoff, Larry Junck, Thomas Kaley, Ryan Merrell, Maciej M. Mrugała, Seema Nagpal, Lucien Nedzi, Kathryn Nevel, Phioanh L. Nghiemphu, Ian F. Parney, Toral Patel, Katherine B. Peters, Vinay K. Puduvalli, Jason K. Rockhill, Chad G. Rusthoven, Nicole Shonka, Lode J. Swinnen, Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan Darlow - Journal of the National Comprehensive Cancer Network 2023 cited by 223

  7. A multiprotein supercomplex controlling oncogenic signalling in lymphoma

    Authors: James D. Phelan, Ryan M. Young, Daniel E. Webster, Sandrine Roulland, George W. Wright, Monica Kasbekar, Arthur L. Shaffer, Michele Ceribelli, James Q. Wang, Roland Schmitz, Masao Nakagawa, Emmanuel Bachy, Da Wei Huang, Yanlong Ji, Lu Chen, Yandan Yang, Hong Zhao, Xin Yu, Weihong Xu, Maryknoll Palisoc, Racquel Valadez, Theresa Davies‐Hill, Wyndham H. Wilson, Wing C. Chan, Elaine S. Jaffe, Randy D. Gascoyne, Elı́as Campo, Andreas Rosenwald, German Ott, Jan Delabie, Lisa M. Rimsza, Fausto J. Rodríguez, Fayez Estephan, Matthias Holdhoff, Michael J. Kruhlak, Stephen M. Hewitt, Craig J. Thomas, Stefania Pittaluga, Thomas Oellerich, Louis M. Staudt - Nature 2018 cited by 403

  8. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord

    Authors: Yuxuan Wang, Simeon Springer, Ming Zhang, K. Wyatt McMahon, Isaac Kinde, Lisa Dobbyn, Janine Ptak, Henry Brem, Kaisorn L. Chaichana, Gary L. Gallia, Ziya L. Gokaslan, Mari L. Groves, George I. Jallo, Michael Lim, Alessandro Olivi, Alfredo Quiñones‐Hinojosa, Daniele Rigamonti, Greg Riggins, Daniel M. Sciubba, Jon Weingart, Jean‐Paul Wolinsky, Xiaobu Ye, Sueli Mieko Oba‐Shinjo, Suely Kazue Nagahashi Marie, Matthias Holdhoff, Nishant Agrawal, Luis A. Díaz, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Chetan Bettegowda - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 474

  9. Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β

    Authors: Kajal Chaudhry, Ashley Geiger, Ehsan Dowlati, Haili Lang, Danielle Sohai, Eugene Hwang, Christopher A. Lazarski, Eric Yvon, Matthias Holdhoff, R. Brad Jones, Barbara Savoldo, Carolina Colli Cruz, Catherine M. Bollard - Molecular Therapy — Methods & Clinical Development 2022 cited by 43

  10. NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017

    Authors: Burt Nabors, Jana Portnow, Mario Ammirati, Joachim M. Baehring, Henry Brem, Nicholas Butowski, Robert A. Fenstermaker, Peter Forsyth, Jona A. Hattangadi‐Gluth, Matthias Holdhoff, Steven Howard, Larry Junck, Thomas Kaley, Priya Kumthekar, Jay S. Loeffler, Paul L. Moots, Maciej M. Mrugała, Seema Nagpal, Manjari Pandey, Ian F. Parney, Katherine B. Peters, Vinay K. Puduvalli, John W. Ragsdale, Jason K. Rockhill, Lisa R. Rogers, Chad G. Rusthoven, Nicole Shonka, Dennis C. Shrieve, Allen K. Sills, Lode J. Swinnen, Christina Tsien, Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2017 cited by 231

  11. Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy

    Authors: Shanshan Jiang, Charles G. Eberhart, Michael Lim, Hye‐Young Heo, Yi Zhang, Lindsay Blair, Zhibo Wen, Matthias Holdhoff, Doris Lin, Peng Huang, Huamin Qin, Alfredo Quiñones‐Hinojosa, Jon Weingart, Peter B. Barker, Martin G. Pomper, John Laterra, Peter C.M. van Zijl, Jaishri O. Blakeley, Jinyuan Zhou - Clinical Cancer Research 2018 cited by 154

  12. First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma

    Authors: Jordi Rodón, Michael A. Carducci, Juan Manuel Sepúlveda-Sánchez, Analía Azaro, Emiliano Calvo, Joan Seoane, Irene Braña, Elisabet Sicart, Ivelina Gueorguieva, Ann Cleverly, N. Sokalingum Pillay, D. Desaiah, Shawn T. Estrem, Luis Paz‐Ares, Matthias Holdhoff, Jaishri O. Blakeley, Michael Lahn, José Baselga - Clinical Cancer Research 2014 cited by 232

  13. Frequent ATRX , CIC , FUBP1 and IDH1 mutations refine the classification of malignant gliomas

    Authors: Yuchen Jiao, Patrick Killela, Zachary J. Reitman, B. Ahmed Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodríguez, Sérgio Rosemberg, Sueli Mieko Oba‐Shinjo, Suely Kazue Nagahashi Marie, Chetan Bettegowda, Nishant Agrawal, Eric Lipp, Christopher J. Pirozzi, Giselle Y. López, Yiping He, Henry S. Friedman, Allan H. Friedman, Gregory J. Riggins, Matthias Holdhoff, Peter C. Burger, Roger E. McLendon, Darell D. Bigner, Bert Vogelstein, Alan K. Meeker, Kenneth W. Kinzler, Nickolas Papadopoulos, Luis A. Díaz, Hai Yan - Oncotarget 2012 cited by 582

  14. Central Nervous System Cancers, Version 1.2015

    Authors: Burt Nabors, Jana Portnow, Mario Ammirati, Joachim M. Baehring, Henry Brem, Paul D. Brown, Nicholas Butowski, Marc C. Chamberlain, Robert A. Fenstermaker, Allan H. Friedman, Mark R. Gilbert, Jona A. Hattangadi‐Gluth, Matthias Holdhoff, Larry Junck, Thomas Kaley, Ronald Lawson, Jay S. Loeffler, Mary Lovely, Paul L. Moots, Maciej M. Mrugała, Herbert B. Newton, Ian F. Parney, Jeffrey J. Raizer, Lawrence D. Recht, Nicole Shonka, Dennis C. Shrieve, Allen K. Sills, Lode J. Swinnen, David Tran, Nam Tran, Frank D. Vrionis, Stephanie E. Weiss, Patrick Y. Wen, Nicole R. McMillian, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2015 cited by 178

  15. Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma

    Authors: Karen M. Xu, Karthik Ramesh, Vicki Huang, Saumya Gurbani, James S. Cordova, Eduard Schreibmann, Brent D. Weinberg, Soma Sengupta, Alfredo Voloschin, Matthias Holdhoff, Peter B. Barker, Lawrence Kleinberg, Jeffrey J. Olson, Hui‐Kuo G. Shu, Hyunsuk Shim - Tomography 2022 cited by 26

  16. LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT IDH1 OR IDH2 DIFFUSE GLIOMA TUMOR GROWTH RATE: RESULTS FROM THE RANDOMIZED, DOUBLE-BLIND, PHASE 3 INDIGO STUDY

    Authors: Patrick Y. Wen, Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal, Mehdi Touat, Katherine B. Peters, Jennifer Clarke, Joe Mendez, Shlomit Yust‐Katz, Warren Mason, François Ducray, Yoshie Umemura, Burt Nabors, Matthias Holdhoff, Andreas F. Hottinger, Yoshiki Arakawa, Juan Manuel Sepúlveda-Sánchez, Wolfgang Wick, Riccardo Soffietti, James Perry, Pierre Giglio, Macarena de la Fuente, Elizabeth A. Maher, Dan Zhao, Shuchi S. Pandya, Lori Steelman, Islam Hassan, Timothy F. Cloughesy, Benjamin M. Ellingson - Neuro-Oncology 2023 cited by 18

  17. Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer

    Authors: Jordi Rodón, Michael A. Carducci, Juan Manuel Sepúlveda-Sánchez, Analía Azaro, Emiliano Calvo, Joan Seoane, Irene Braña, Elisabet Sicart, Ivelina Gueorguieva, Ann Cleverly, Nischalan Pillay, D. Desaiah, Shawn T. Estrem, Luis Paz‐Ares, Matthias Holdhoff, Jaishri O. Blakeley, Michael Lahn, José Baselga - Investigational New Drugs 2014 cited by 105

  18. Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers

    Authors: Jarushka Naidoo, Karisa C. Schreck, Wei Fu, Chen Hu, Alexander Carvajal-González, Roisín M. Connolly, Cesar A. Santa‐Maria, Evan J. Lipson, Matthias Holdhoff, Patrick M. Forde, Christopher Douville, Joanne Riemer, Amanda Barnes, Kristin J. Redmond, Lawrence Kleinberg, B.R. Page, Nafi Aygün, Kenneth W. Kinzler, Nickolas Papadopoulos, Chetan Bettegowda, Arun Venkatesan, Julie R. Brahmer, Stuart A. Grossman - Journal for ImmunoTherapy of Cancer 2021 cited by 67

  19. Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid

    Authors: Christopher Douville, Samuel M. Curtis, Mahmoud Summers, Tej D. Azad, Jordina Rincón-Torroella, Yuxuan Wang, Austin K. Mattox, Bracha Erlanger Avigdor, Jonathan A. Dudley, Joshua Materi, Divyaansh Raj, Sumil K. Nair, Debarati Bhanja, Kyle Tuohy, Lisa Dobbyn, Maria Popoli, Janine Ptak, Nadine T. Nehme, Natalie Silliman, Cheríe Blair, Kathy Judge, Gary L. Gallia, Mari L. Groves, Christopher M. Jackson, Eric M. Jackson, John Laterra, Michael Lim, Debraj Mukherjee, Jon Weingart, Jarushka Naidoo, Carl Koschmann, Natalya Smith, Karisa C. Schreck, Carlos A. Pardo, Michael Glantz, Matthias Holdhoff, Kenneth W. Kinzler, Nickolas Papadopoulos, Bert Vogelstein, Chetan Bettegowda - Cell Reports Medicine 2023 cited by 18

  20. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas

    Authors: Karisa C. Schreck, Surabhi Ranjan, Nebojša Skorupan, Chetan Bettegowda, Charles G. Eberhart, Heather M. Ames, Matthias Holdhoff - Journal of Neuro-Oncology 2019 cited by 128

  21. MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas

    Authors: Naema Nayyar, Michael White, Corey M. Gill, Matthew Lastrapes, Mia Bertalan, Alexander Kaplan, Megan R. D’Andrea, Ivanna V. Bihun, Andrew Kaneb, Jörg Dietrich, Judith A. Ferry, Maria Martinez‐Lage, Anita Giobbie‐Hurder, Darrell R. Borger, Fausto J. Rodríguez, Matthew P. Frosch, Emily Batchelor, Kaitlin Hoang, Benjamin M. Kuter, S.A.M. Fortin, Matthias Holdhoff, Daniel P. Cahill, Scott L. Carter, Priscilla K. Brastianos, Tracy T. Batchelor - Blood Advances 2019 cited by 127

  22. Systemic use of tumor necrosis factor alpha as an anticancer agent

    Authors: Nicholas J. Roberts, Shibin Zhou, Luis A. Díaz, Matthias Holdhoff - Oncotarget 2011 cited by 177

  23. A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma

    Authors: Karthik Ramesh, Eric A. Mellon, Saumya Gurbani, Brent D. Weinberg, Eduard Schreibmann, Sulaiman Sheriff, Mohammed Goryawala, Macarena de le Fuente, Bree R. Eaton, Jim Zhong, Alfredo Voloschin, Soma Sengupta, Erin Dunbar, Matthias Holdhoff, Peter B. Barker, Andrew A. Maudsley, Lawrence Kleinberg, Hyunsuk Shim, Hui‐Kuo G. Shu - Neuro-Oncology Advances 2022 cited by 41

  24. Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

    Authors: Eudocia Q. Lee, Michael Weller, Joohee Sul, Stephen Bagley, Solmaz Sahebjam, Martin J. van den Bent, Manmeet S. Ahluwalia, Jian Campian, Evanthia Galanis, Mark R. Gilbert, Matthias Holdhoff, Glenn J. Lesser, Frank S. Lieberman, Minesh P. Mehta, Marta Peñas-Prado, Karisa C. Schreck, Roy E. Strowd, Michael A. Vogelbaum, Tobias Walbert, Susan M. Chang, Burt Nabors, Stuart A. Grossman, David A. Reardon, Patrick Y. Wen - Neuro-Oncology 2020 cited by 40